查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1656909

防回流設備的全球市場:洞察，競爭情形，市場預測:2032年

Anti-retropulsion Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

預計在預測期內，即 2025-2032 年，防回流裝置市場規模將以 6.69% 的複合年增長率擴大。預防逆流設備的需求不斷增加，主要是由於腎結石發病率不斷上升，而腎結石通常與脫水等因素有關。此外，良性前列腺增生 (BPH)、肥胖和久坐的生活方式等風險因素負擔的增加（這些是腎結石發展的關鍵風險因素）進一步促進了市場的成長。防回流裝置的技術進步以及主要參與者的持續研發努力也在推動預測期（即 2025-2032 年）防回流裝置市場積極成長方面發揮關鍵作用。

腎結石（尿石症）盛行率的上升是推動逆流預防設備市場擴張的關鍵因素。根據英國腎臟研究中心 2023 年 10 月的數據，英國大約每 10 人就有 1 人患有腎結石。

根據加拿大泌尿科 2023 年的數據，加拿大大約每 10 人中就有 1 人在一生中的某個階段會患上腎結石。該病在男性中比女性更常見，並且各個地區的活躍病例都在增加。腎結石發病率的不斷上升推動了相關醫療器材和治療市場的成長。防逆流裝置在腎結石的治療中發揮重要作用，尤其是在輸尿管鏡檢查和碎石術等手術過程中。這些裝置是專門為防止結石碎片在治療過程中返回腎臟而設計的。由於全球腎結石病例不斷增加，對包括反流預防裝置在內的先進醫療解決方案的需求預計將持續上升，進一步促進市場的擴張。

肥胖和久坐的生活方式的增加是腎結石的主要風險因素，進一步推動了市場的成長。根據世界衛生組織（WHO）2024年2月的數據，到2022年肥胖將影響全球超過10億人，其中包括6.5億成年人、3.4億青少年和3,900萬名兒童。預計這一數字將繼續增長，增加對腎結石治療的需求，從而推動市場成長。

然而，設備相關併發症風險、熟練專業人員短缺以及低收入國家獲得抗逆流設備的有限等挑戰可能會成為市場成長的限制因素。

本報告提供全球防回流設備市場相關調查，提供市場概要，以及各產品類型，各終端用戶，各地區趨勢，及加入此市場的主要企業簡介等資訊。

目錄

第1章 抗逆流設備市場報告的簡介

第2章 防回流設備市場摘要整理

第3章 競爭情形

第4章 法規分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第5章 抗逆流設備市場主要原因分析

  • 防回流設備市場促進因素
  • 防回流設備市場阻礙因素與課題
  • 防回流設備市場機會

第6章 防回流設備市場上波特的五力分析

第7章 逆噴射防止設備的市場評估

  • 各產品類型
    • 結石捕獲和提取裝置
    • 結石回收裝置
    • 其他
  • 各終端用戶
    • 醫院
    • 門診病人手術中心
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 其他地區

第8章 防回流設備市場企業與產品簡介

  • Boston Scientific Corporation
  • Cook
  • Rocamed
  • Accordion Medical
  • EndoTheia, Inc.
  • KARL STORZ
  • Olympus Corporation
  • Coloplast Group
  • Endotherapeutics Pty Ltd.
  • ELMED Medical Systems
  • PENTAX Medical
  • UROMED Kurt Drews KG
  • BD
  • Dornier MedTech
  • NeoScope Inc.
  • OTU Medical
  • Clarion Medical Technologies
  • Calyxo, Inc.
  • EMS Urology
  • Happiness Works Medical

第9章 KOL的見解

第10章 計劃的方法

第11章 關於DelveInsight

第12章 免責聲明和諮詢方式

Product Code: DIMDCL0394

Anti-retropulsion Devices Market by Product Type (Stone Entrapment and Extraction Devices, Stone Retrieval Devices, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 due to the growing prevalence of kidney stones and increasing R&D activiites and product launches in anti-retropulsion devices.

The anti-retropulsion devices market is estimated to grow at a CAGR of 6.69% during the forecast period from 2025 to 2032. The increasing demand for anti-retropulsion devices is primarily driven by the rising prevalence of kidney stones which are often linked to factors like dehydration. Additionally, the growing burden of risk factors such as benign prostatic hyperplasia (BPH), obesity, and sedentary lifestyles, both of which are significant risk factors for the development of kidney stones, further contribute to the market's growth. Technological advancements in anti-retropulsion devices, along with ongoing research and development efforts by key players, are also playing a pivotal role in propelling the positive growth of the anti-retropulsion devices market during the forecast period from 2025 to 2032.

Anti-retropulsion Devices Market Dynamics:

The growing prevalence of kidney stones (urolithiasis) is a key factor driving the expansion of the anti-retropulsion devices market. According to Kidney Research UK data from October 2023, kidney stones affect approximately one in ten individuals in the United Kingdom.

According to data from the Canadian Urological Association in 2023, approximately one in ten people develop a kidney stone at some point in their life in Canada. This condition is more prevalent in men than in women, with active cases on the rise in various regions. This increasing incidence of kidney stones is driving the growth of the market for related medical devices and treatments. Anti-retropulsion devices play a critical role in the management of kidney stones, particularly during procedures like ureteroscopy and lithotripsy. These devices are specifically designed to prevent the migration of stone fragments back into the kidney during treatment. With the growing number of kidney stone cases worldwide, the demand for advanced medical solutions, including anti-retropulsion devices, is expected to continue rising, further contributing to the market's expansion.

The growing incidence of obesity and sedentary lifestyles-key risk factors for kidney stones-further drives market growth. According to the World Health Organization (WHO) in February 2024, over 1 billion people worldwide were affected by obesity in 2022, including 650 million adults, 340 million adolescents, and 39 million children. This number is expected to rise, creating a greater demand for kidney stone treatments, thereby driving the market growth.

However, challenges such as the risk of device-related complications, lack of skilled professionals, and limited access to anti-retropulsion devices in low-income countries may act as barriers to market growth.

Anti-retropulsion Devices Market Segment Analysis:

Anti-retropulsion Devices Market by Product Type (Stone Entrapment and Extraction Devices, Stone Retrieval Devices, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the anti-retropulsion devices, stone entrapment and extraction devices are expected to capture the largest market share during the forecast period. The is attributed to various advantages associated with these devices. Stone entrapment and extraction devices are highly effective tools for removing kidney stones from the urinary tract, while also minimizing the risk of stone migration.

These devices offer minimally invasive solutions, meaning smaller incisions or no incisions at all, which results in less pain, a lower risk of infection, and quicker recovery times compared to traditional open surgery. For larger stones or those located in difficult-to-reach areas, stone extraction through entrapment proves to be particularly beneficial. These devices are designed to fragment stones into smaller pieces, making them easier to remove or pass naturally, reducing the need for more invasive procedures. This approach not only improves patient comfort but also contributes to more efficient treatment outcomes, promoting faster recovery and preserving overall kidney function.

Stone entrapment and extraction devices also play a crucial role in preventing the proximal migration of stones and fragments during ureteroscopy. This is essential for maintaining visibility and access to the stone, ensuring that the procedure is efficient and reduces the risk of complications associated with stone migration back into the kidney. For instance, devices like the EscapeTM Nitinol Stone Retrieval Device by Boston Scientific are specifically designed to facilitate smoother procedures by minimizing retropulsion, a common issue that can lead to longer operative times and increased procedure complexity.

In addition, the innovative technologies within the stone entrapment and extraction devices category, combined with their growing applications in urological procedures, are expected to significantly drive market growth. As the demand for more effective treatment solutions increases, the anti-retropulsion devices market is set to expand further throughout the forecast period.

North America is expected to dominate the overall anti-retropulsion devices market:

North America is projected to dominate the anti-retropulsion devices market during the forecast period from 2025 to 2032. This growth can be attributed to several critical drivers, including the increasing incidence of kidney stones and urinary cancers, as well as a rise in risk factors associated with kidney stone formation. Furthermore, advancements in technology related to the development of anti-retropulsion devices, coupled with a strong healthcare infrastructure, are expected to significantly propel market expansion in the region.

According to data from the American Kidney Fund (2024), over 1 in 10 men and approximately 1 in 14 women in the United States experienced kidney stones at least once in their lifetime. Additionally, data from the National Institutes of Health (NIH) in 2023 highlighted that kidney stone affects 1 in 11 people, with an estimated 600,000 new cases reported in the United States annually. The rising prevalence of kidney stones is significantly driving the growth of the anti-retropulsion devices market in the region.

The increasing incidence of upper tract urothelial carcinoma (UTUC) and kidney diseases is also a significant driver for the growing demand for anti-retropulsion devices. Patients with urinary cancers and other urinary tract conditions face an elevated risk of developing renal stones, exacerbating the need for effective anti-retropulsion interventions. According to data from the Center for Disease Control and Prevention (CDC) published in June 2024, approximately 35 million cases of chronic kidney disease (CKD) were reported in the United States in 2023. CKD impairs kidney function, leading to the formation and accumulation of renal stones, thereby fueling demand for anti-retropulsion devices and promoting market expansion.

Anti-retropulsion Devices Market Key Players:

Some of the key market players operating in the anti-retropulsion devices market include Boston Scientific Corporation, Cook, Rocamed, Accordion Medical, EndoTheia, Inc., KARL STORZ, Olympus Corporation, Coloplast Group, Endotherapeutics Pty Ltd., ELMED Medical Systems, PENTAX Medical, UROMED Kurt Drews KG, BD, Dornier MedTech, NeoScope Inc., OTU Medical, Clarion Medical Technologies, Calyxo, Inc., EMS Urology, Happiness Works Medical, and others.

Recent Developmental Activities in the Anti-retropulsion Devices Market:

  • In November 2024, EndoTheia, Inc., a frontrunner in innovative surgical technology, announced the successful completion of the first-in-human clinical trial for its FlexStone(TM) Basket. The cutting-edge device provides unmatched flexibility and control, allowing for the retrieval of stones from difficult-to-reach and challenging locations, thereby enhancing the precision and effectiveness of stone removal procedures. The success of this trial marked a significant milestone in advancing minimally invasive treatments for kidney stones.

Key Takeaways from the Anti-retropulsion Devices Market Report Study

  • Market size analysis for current Anti-retropulsion Devices Market size (2024), and market forecast for 8 years (2025 to 2032)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
  • Key companies dominating the Anti-retropulsion Devices market.
  • Various opportunities are available for the other competitors in the Anti-retropulsion Devices Market space.
  • What are the top-performing segments in 2024? How these segments will perform in 2032?
  • Which are the top-performing regions and countries in the current Anti-retropulsion Devices market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for Anti-retropulsion Devices market growth in the coming future?

Target Audience who can be benefited from this Anti-retropulsion Devices Market Report Study

  • Anti-retropulsion Devices product providers
  • Research organizations and consulting companies
  • Anti-retropulsion Devices related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and Traders dealing in Anti-retropulsion Devices
  • Various end-users who want to know more about the Anti-retropulsion Devices Market and the latest technological developments in the Anti-retropulsion Devices Market.

Frequently Asked Questions for the Anti-retropulsion Devices Market:

1. What are Anti-retropulsion Devices?

  • Anti-retropulsion devices for kidney stones are medical instruments designed to prevent the backward movement (retropulsion) of kidney stones during minimally invasive procedures, such as ureteroscopy or lithotripsy. When a stone is being fragmented or removed, there is a risk that it could move away from the targeted area, potentially causing complications or making the procedure less effective.

2. What is the market for ureteroscopes?

  • The anti-retropulsion devices market is estimated to grow at a CAGR of 6.69% during the forecast period from 2025 to 2032.

3. What are the drivers for the Anti-retropulsion Devices market?

  • The increasing demand for anti-retropulsion devices is primarily driven by the rising prevalence of kidney stones which are often linked to factors like dehydration. Additionally, the growing burden of risk factors such as benign prostatic hyperplasia (BPH), obesity, and sedentary lifestyles, both of which are significant risk factors for the development of kidney stones, further contribute to the market's growth. Technological advancements in anti-retropulsion devices, along with ongoing research and development efforts by key players, are also playing a pivotal role in propelling the positive growth of the anti-retropulsion devices market during the forecast period from 2025 to 2032.

4. Who are the key players operating in the Anti-retropulsion Devices market?

  • Some of the key market players operating in the anti-retropulsion devices market include Boston Scientific Corporation, Cook, Rocamed, Accordion Medical, EndoTheia, Inc., KARL STORZ, Olympus Corporation, Coloplast Group, Endotherapeutics Pty Ltd., ELMED Medical Systems, PENTAX Medical, UROMED Kurt Drews KG, BD, Dornier MedTech, NeoScope Inc., OTU Medical, Clarion Medical Technologies, Calyxo, Inc., EMS Urology, Happiness Works Medical, and others.

5. Which region has the highest share in the Anti-retropulsion Devices market?

  • North America is projected to dominate the ureteroscope market during the forecast period from 2025 to 2032. This growth can be attributed to several critical drivers, including the increasing incidence of kidney stones and urinary cancers, as well as a rise in risk factors associated with kidney stone formation. Furthermore, advancements in technology related to the development of anti-retropulsion devices, coupled with a strong healthcare infrastructure, are expected to significantly propel market expansion in the region.

Table of Contents

1. Anti-retropulsion Devices Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Anti-retropulsion Devices Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Anti-retropulsion Devices Market Key Factors Analysis

  • 5.1. Anti-retropulsion Devices Market Drivers
    • 5.1.1. The growing prevalence of kidney stones
    • 5.1.2. The growing burden of risk factors such as benign prostatic hyperplasia (BPH), obesity, and sedentary lifestyles
    • 5.1.3. Technological advancements in anti-retropulsion devices, along with ongoing research and development efforts by key players
  • 5.2. Anti-retropulsion Devices Market Restraints and Challenges
    • 5.2.1. Risks of device-associated complications
    • 5.2.2. Lack of skilled professionals, and limited access to anti-retropulsion devices in low-income countries
  • 5.3. Anti-retropulsion Devices Market Opportunity
    • 5.3.1. Shift towards minimally invasive procedures

6. Anti-retropulsion Devices Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Anti-retropulsion Devices Market Assessment

  • 7.1. By Product Type
    • 7.1.1. Stone Entrapment and Extraction Devices
    • 7.1.2. Stone Retrieval Devices
    • 7.1.3. Others
  • 7.2. By End-User
    • 7.2.1. Hospitals
    • 7.2.2. Ambulatory Surgical Centers
    • 7.2.3. Others
  • 7.3. By Geography
    • 7.3.1. North America
      • 7.3.1.1. United States Anti-retropulsion Devices Market Size in USD million (2022-2032)
      • 7.3.1.2. Canada Anti-retropulsion Devices Market Size in USD million (2022-2032)
      • 7.3.1.3. Mexico Anti-retropulsion Devices Market Size in USD million (2022-2032)
    • 7.3.2. Europe
      • 7.3.2.1. France Anti-retropulsion Devices Market Size in USD million (2022-2032)
      • 7.3.2.2. Germany Anti-retropulsion Devices Market Size in USD million (2022-2032)
      • 7.3.2.3. United Kingdom Anti-retropulsion Devices Market Size in USD million (2022-2032)
      • 7.3.2.4. Italy Anti-retropulsion Devices Market Size in USD million (2022-2032)
      • 7.3.2.5. Spain Anti-retropulsion Devices Market Size in USD million (2022-2032)
      • 7.3.2.6. Rest of Europe Anti-retropulsion Devices Market Size in USD million (2022-2032)
    • 7.3.3. Asia-Pacific
      • 7.3.3.1. China Anti-retropulsion Devices Market Size in USD million (2022-2032)
      • 7.3.3.2. Japan Anti-retropulsion Devices Market Size in USD million (2022-2032)
      • 7.3.3.3. India Anti-retropulsion Devices Market Size in USD million (2022-2032)
      • 7.3.3.4. Australia Anti-retropulsion Devices Market Size in USD million (2022-2032)
      • 7.3.3.5. South Korea Anti-retropulsion Devices Market Size in USD million (2022-2032)
      • 7.3.3.6. Rest of Asia-Pacific Anti-retropulsion Devices Market Size in USD million (2022-2032)
    • 7.3.4. Rest of the World (RoW)
      • 7.3.4.1. Middle East Anti-retropulsion Devices Market Size in USD million (2022-2032)
      • 7.3.4.2. Africa Anti-retropulsion Devices Market Size in USD million (2022-2032)
      • 7.3.4.3. South America Anti-retropulsion Devices Market Size In USD Million (2022-2032)

8. Anti-retropulsion Devices Market Company and Product Profiles

  • 8.1. Boston Scientific Corporation
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Cook
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Rocamed
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. Accordion Medical
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. EndoTheia, Inc.
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. KARL STORZ
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. Olympus Corporation
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. Coloplast Group
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Endotherapeutics Pty Ltd.
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. ELMED Medical Systems
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. PENTAX Medical
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. UROMED Kurt Drews KG
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. BD
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. Dornier MedTech
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. NeoScope Inc.
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy
  • 8.16. OTU Medical
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4. Product Listing
    • 8.16.5. Entropy
  • 8.17. Clarion Medical Technologies
    • 8.17.1. Company Overview
    • 8.17.2. Company Snapshot
    • 8.17.3. Financial Overview
    • 8.17.4. Product Listing
    • 8.17.5. Entropy
  • 8.18. Calyxo, Inc.
    • 8.18.1. Company Overview
    • 8.18.2. Company Snapshot
    • 8.18.3. Financial Overview
    • 8.18.4. Product Listing
    • 8.18.5. Entropy
  • 8.19. EMS Urology
    • 8.19.1. Company Overview
    • 8.19.2. Company Snapshot
    • 8.19.3. Financial Overview
    • 8.19.4. Product Listing
    • 8.19.5. Entropy
  • 8.20. Happiness Works Medical
    • 8.20.1. Company Overview
    • 8.20.2. Company Snapshot
    • 8.20.3. Financial Overview
    • 8.20.4. Product Listing
    • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Anti-retropulsion Devices Market in Global (2022-2032)
  • Table 3: Anti-retropulsion Devices Market in Global by Product Type (2022-2032)
  • Table 4: Anti-retropulsion Devices Market in Global by End-User (2022-2032)
  • Table 5: Anti-retropulsion Devices Market in Global by Geography (2022-2032)
  • Table 6: Anti-retropulsion Devices Market in North America (2022-2032)
  • Table 7: Anti-retropulsion Devices Market in the United States (2022-2032)
  • Table 8: Anti-retropulsion Devices Market in Canada (2022-2032)
  • Table 9: Anti-retropulsion Devices Market in Mexico (2022-2032)
  • Table 10: Anti-retropulsion Devices Market in Europe (2022-2032)
  • Table 11: Anti-retropulsion Devices Market in France (2022-2032)
  • Table 12: Anti-retropulsion Devices Market in Germany (2022-2032)
  • Table 13: Anti-retropulsion Devices Market in United Kingdom (2022-2032)
  • Table 14: Anti-retropulsion Devices Market in Italy (2022-2032)
  • Table 15: Anti-retropulsion Devices Market in Spain (2022-2032)
  • Table 16: Anti-retropulsion Devices Market in Rest of Europe (2022-2032)
  • Table 17: Anti-retropulsion Devices Market in Asia-Pacific (2022-2032)
  • Table 18: Anti-retropulsion Devices Market in China (2022-2032)
  • Table 19: Anti-retropulsion Devices Market in Japan (2022-2032)
  • Table 20: Anti-retropulsion Devices Market in India (2022-2032)
  • Table 21: Anti-retropulsion Devices Market in Australia (2022-2032)
  • Table 22: Anti-retropulsion Devices Market in South Korea (2022-2032)
  • Table 23: Anti-retropulsion Devices Market in Rest of Asia-Pacific (2022-2032)
  • Table 24: Anti-retropulsion Devices Market in the Rest of the World (2022-2032)
  • Table 25: Anti-retropulsion Devices Market in the Middle East (2022-2032)
  • Table 26: Anti-retropulsion Devices Market in Africa (2022-2032)
  • Table 27: Anti-retropulsion Devices Market in South America (2022-2032)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Anti-retropulsion Devices Market in Global (2022-2032)
  • Figure 3: Anti-retropulsion Devices Market in Global by Product Type (2022-2032)
  • Figure 4: Anti-retropulsion Devices Market in Global by End-User (2022-2032)
  • Figure 5: Anti-retropulsion Devices Market in Global by Geography (2022-2032)
  • Figure 6: Anti-retropulsion Devices Market in North America (2022-2032)
  • Figure 7: Anti-retropulsion Devices Market in the United States (2022-2032)
  • Figure 8: Anti-retropulsion Devices Market in Canada (2022-2032)
  • Figure 9: Anti-retropulsion Devices Market in Mexico (2022-2032)
  • Figure 10: Anti-retropulsion Devices Market in Europe (2022-2032)
  • Figure 11: Anti-retropulsion Devices Market in France (2022-2032)
  • Figure 12: Anti-retropulsion Devices Market in Germany (2022-2032)
  • Figure 13: Anti-retropulsion Devices Market in United Kingdom (2022-2032)
  • Figure 14: Anti-retropulsion Devices Market in Italy (2022-2032)
  • Figure 15: Anti-retropulsion Devices Market in Spain (2022-2032)
  • Figure 16: Anti-retropulsion Devices Market in Rest of Europe (2022-2032)
  • Figure 17: Anti-retropulsion Devices Market in Asia-Pacific (2022-2032)
  • Figure 18: Anti-retropulsion Devices Market in China (2022-2032)
  • Figure 19: Anti-retropulsion Devices Market in Japan (2022-2032)
  • Figure 20: Anti-retropulsion Devices Market in India (2022-2032)
  • Figure 21: Anti-retropulsion Devices Market in Australia (2022-2032)
  • Figure 22: Anti-retropulsion Devices Market in South Korea (2022-2032)
  • Figure 23: Anti-retropulsion Devices Market in Rest of Asia-Pacific (2022-2032)
  • Figure 24: Anti-retropulsion Devices Market in the Rest of the World (2022-2032)
  • Figure 25: Anti-retropulsion Devices Market in the Middle East (2022-2032)
  • Figure 26: Anti-retropulsion Devices Market in Africa (2022-2032)
  • Figure 27: Anti-retropulsion Devices Market in South America (2022-2032)
  • Figure 28: Market Drivers
  • Figure 29: Market Barriers
  • Figure 30: Marker Opportunities
  • Figure 31: PORTER'S Five Force Analysis